Inhibitory effects of procainamide and probenecid on renal excretion of sultopride enantiomers in rats. 1993

A Kamizono, and N Inotsume, and S Fukushima, and M Nakano, and Y Okamoto
Department of Pharmacy, Kumamoto University Hospital, Japan.

The effects of the coadministration of procainamide and probenecid on the pharmacokinetic behavior of sultopride, an antipsychotic agent, after intravenous administration were studied with rats. The areas under the concentration-time curve for and renal clearances of (+)-sultopride and (-)-sultopride, which exist as organic cations under physiological pH conditions, were significantly decreased (p < 0.01) by the coadministration of procainamide, an organic cation under physiological pH conditions. The renal clearance of (-)-sultopride was partially decreased (p < 0.05) by the coadministration of probenecid, an organic anion under physiological pH conditions. The results suggest that drug-drug interactions between organic cations and organic anions occur to a certain extent during the tubular secretion process in rats.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D011342 Procainamide A class Ia antiarrhythmic drug that is structurally-related to PROCAINE. Procaine Amide,Apo-Procainamide,Biocoryl,Novocainamide,Novocamid,Procainamide Hydrochloride,Procamide,Procan,Procan SR,Procanbid,Pronestyl,Rhythmin,Amide, Procaine,Hydrochloride, Procainamide
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D000077582 Amisulpride A benzamide derivative that is used as an antipsychotic agent for the treatment of schizophrenia. It is also used as an antidepressive agent. 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide,Barnetil,DAN 2163,DAN-2163,LIN 1418,LIN-1418,N-(Ethyl-1-pyrrolidinyl- 2-methyl)methoxy-2-ethylsulfonyl-5-benzamide,Solian,Sultopride,Sultopride Hydrochloride
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer

Related Publications

A Kamizono, and N Inotsume, and S Fukushima, and M Nakano, and Y Okamoto
January 1976, Acta biologica et medica Germanica,
A Kamizono, and N Inotsume, and S Fukushima, and M Nakano, and Y Okamoto
January 1995, The Journal of pharmacology and experimental therapeutics,
A Kamizono, and N Inotsume, and S Fukushima, and M Nakano, and Y Okamoto
September 1991, Annals of the rheumatic diseases,
A Kamizono, and N Inotsume, and S Fukushima, and M Nakano, and Y Okamoto
January 1990, Journal of clinical pharmacology,
A Kamizono, and N Inotsume, and S Fukushima, and M Nakano, and Y Okamoto
January 1989, Advances in experimental medicine and biology,
A Kamizono, and N Inotsume, and S Fukushima, and M Nakano, and Y Okamoto
January 1988, Nephron,
A Kamizono, and N Inotsume, and S Fukushima, and M Nakano, and Y Okamoto
February 1998, Antimicrobial agents and chemotherapy,
A Kamizono, and N Inotsume, and S Fukushima, and M Nakano, and Y Okamoto
June 1982, Archives internationales de pharmacodynamie et de therapie,
A Kamizono, and N Inotsume, and S Fukushima, and M Nakano, and Y Okamoto
January 1973, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology,
A Kamizono, and N Inotsume, and S Fukushima, and M Nakano, and Y Okamoto
December 1970, Life sciences. Pt. 1: Physiology and pharmacology,
Copied contents to your clipboard!